NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00101205 2014-02-24Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated40 enrolled
NCT01307592 2014-01-10Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Unknown70 enrolled
NCT00006473 2013-01-23Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 2 Completed72 enrolled